TCL Archive FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer April 29, 1988
TCL Archive Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal December 16, 2011
TCL Archive IOM Committee Focuses on Studies Needed To Protect Patients On Omics-Based Trials November 4, 2011
TCL Archive NCI To Fund 160 P01s FY91, About same As Last Year; Considering New ‘Interactive’ R01 June 21, 1991
